BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30716208)

  • 1. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Kwong AJ; Kim WR; Flemming JA
    Hepatology; 2018 Oct; 68(4):1288-1297. PubMed ID: 29672886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
    Jacob JS; Shaikh A; Goli K; Rich NE; Benhammou JN; Ahmed A; Kim D; Rana A; Goss JA; Naggie S; Lee TH; Kanwal F; Cholankeril G
    Clin Infect Dis; 2023 Feb; 76(4):592-599. PubMed ID: 36221143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.
    Puigvehí M; Hashim D; Haber PK; Dinani A; Schiano TD; Asgharpour A; Kushner T; Kakked G; Tabrizian P; Schwartz M; Gurakar A; Dieterich D; Boffetta P; Friedman SL; Llovet JM; Saberi B
    Am J Transplant; 2020 Jan; 20(1):220-230. PubMed ID: 31437349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
    Lanini S; Nanni Costa A; Grossi PA; Procaccio F; Ricci A; Capobianchi MR; Terrault NA; Ippolito G
    Liver Int; 2016 Mar; 36(3):410-7. PubMed ID: 26264452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience.
    Elbeshbeshy H; Modi N; Patel T; Matthews I; Kampert T; Lee J; Okeke R; Caliskan Y; Fleetwood V; Varma C; Gabris B; Bastani B; Abu Al Rub F; Guenette A; Befeler A; Agbim U; Desai R; Alsabbagh E; Qureshi K; Schnitzler M; Lentine KL; Randall HB; Nazzal M
    Clin Transplant; 2024 Jan; 38(1):e15161. PubMed ID: 37842872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
    Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post-transplant viremia.
    Khan S; Mazumder R; Wang X; Wang Y; Sims OT; Budev M; Carey W
    Clin Transplant; 2024 May; 38(5):e15325. PubMed ID: 38716770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States.
    Kwong A; Kim WR; Mannalithara A; Heo NY; Udompap P; Kim D
    Liver Transpl; 2018 Jun; 24(6):735-743. PubMed ID: 29125676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of risk prediction models for post-liver transplant patient and graft survival over time.
    Shaffer L; Abu-Gazala S; Schaubel DE; Abt P; Mahmud N
    Liver Transpl; 2024 Jul; 30(7):689-698. PubMed ID: 38265295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
    Chhatwal J; Samur S; Kues B; Ayer T; Roberts MS; Kanwal F; Hur C; Donnell DM; Chung RT
    Hepatology; 2017 Mar; 65(3):777-788. PubMed ID: 27906468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in use and three-year outcomes of hepatitis C virus-viremic donor lung transplants for hepatitis C virus-seronegative recipients.
    Ruck JM; Zeiser LB; Zhou AL; Chidi AP; Winchester SL; Durand CM; Ha JS; Shah PD; Massie AB; Segev DL; Merlo CA; Bush EL
    J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1587-1595.e2. PubMed ID: 36207160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver grafts for transplantation from donors with diabetes: an analysis of the Scientific Registry of Transplant Recipients database.
    Zheng J; Xiang J; Zhou J; Li Z; Hu Z; Lo CM; Wang W
    PLoS One; 2014; 9(5):e98104. PubMed ID: 24847864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of hepatitis C virus infected donors in heart transplant recipients with elevated MELD-XI score.
    Hirani R; Okumura K; Isath A; Gregory V; Khan S; Dhand A; Lanier GM; Spielvogel D; Kai M; Ohira S
    Clin Transplant; 2023 Dec; 37(12):e15124. PubMed ID: 37688341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcomes of kidney after liver transplantation after the implementation of the safety net policy.
    Attieh RM; Ibrahim RM; Ghali P; Keaveny A; Croome K; Hodge D; White L; Wadei HM
    Liver Transpl; 2024 Jun; 30(6):582-594. PubMed ID: 38015446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ Transplantation Registry Data Analysis.
    Park H; Lee H; Baik S; Kim MS; Yang J; Jeong JC; Koo TY; Kim DG; Lee JM
    Ann Transplant; 2024 May; 29():e943588. PubMed ID: 38769724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C: New challenges in liver transplantation.
    Filipec Kanizaj T; Kunac N
    World J Gastroenterol; 2015 May; 21(19):5768-77. PubMed ID: 26019441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of direct-acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients.
    Bixby AL; Fitzgerald L; Leek R; Mellinger J; Sharma P; Tischer S
    Transpl Infect Dis; 2019 Jun; 21(3):e13078. PubMed ID: 30884055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.
    Dultz G; Graubard BI; Martin P; Welker MW; Vermehren J; Zeuzem S; McGlynn KA; Welzel TM
    PLoS One; 2017; 12(10):e0186898. PubMed ID: 29088255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease.
    Flohr TR; Bonatti H; Hranjec T; Keith DS; Lobo PI; Kumer SC; Schmitt TM; Sawyer RG; Pruett TL; Roberts JP; Brayman KL
    J Surg Res; 2012 Aug; 176(2):629-38. PubMed ID: 22316669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.